From what they said it doesn't actually need to be individually produced. Rather, there are 34 possible targets, which ones are actually used depends on the pa

From what they said it doesn't actually need to be individually produced. Rather, there are 34 possible targets, which ones are actually used depends on the patient's cancer. You aim at the targets which the tumor expresses, the others would simply cause side effects for no gain. Thus, instead of custom manufacture your distribution system is 34 separate compounds, the patient receives whatever combination would be best for their tumor. Probably not viable at the ordinary pharmacy level, but viable at the cancer center level or a compounding pharmacy.